Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 31.95% is in line with its 5-year average of 31.56%, around the middle of its 5-year range (28.54%–35.76%).
0.01% below its 12-month average of 31.95%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-07-04): 32.59%.
GROSS MARGIN
31.95%
GROSS MARGIN AVG TTM
31.95%
GROSS MARGIN AVG 3Y
31.63%
GROSS MARGIN AVG 5Y
31.56%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-0.01%
CURRENT VS 3Y AVG
+1.02%
CURRENT VS 5Y AVG
+1.24%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
47.19%
median of 504 covered companies
CURRENT VS SECTOR MEDIAN
-32.29%
vs the sector median at left
Aveanna Healthcare Holdings Inc.
Market Cap
$2.68B
Gross Margin
31.95%
TTM Avg
31.95%
3Y Avg
31.63%
5Y Avg
31.56%
Market Cap
$2.68B
Gross Margin
17.61%
TTM Avg
20.09%
3Y Avg
39.91%
5Y Avg
58.59%
Market Cap
$2.69B
Gross Margin
56.20%
TTM Avg
28.10%
3Y Avg
28.10%
5Y Avg
28.10%
Market Cap
$2.76B
Gross Margin
84.05%
TTM Avg
-197.31%
3Y Avg
-176.53%
5Y Avg
-71811.06%
Market Cap
$2.87B
Gross Margin
58.69%
TTM Avg
59.64%
3Y Avg
63.22%
5Y Avg
64.62%
Market Cap
$2.51B
Gross Margin
-61.96%
TTM Avg
-19.42%
3Y Avg
-14.39%
5Y Avg
23.74%
Market Cap
$2.89B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aveanna Healthcare Holdings Inc. (AVAH) | $2.68B | 31.95% | 31.95% | 31.63% | 31.56% |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.68B | 17.61% | 20.09% | 39.91% | 58.59% |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.69B | 56.20% | 28.10% | 28.10% | 28.10% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.76B | 84.05% | -197.31% | -176.53% | -71811.06% |
| AtriCure, Inc. (ATRC)vs › | $2.85B | 76.16% | 74.55% | 74.69% | 74.35% |
| TransMedics Group, Inc. (TMDX)vs › | $2.87B | 58.69% | 59.64% | 63.22% | 64.62% |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.51B | -61.96% | -19.42% | -14.39% | 23.74% |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.89B | 0.00% | 0.00% | 0.00% | 0.00% |
| Disc Medicine, Inc. (IRON)vs › | $2.43B | 0.00% | 0.00% | 0.00% | 0.00% |
| Clover Health Investments, Corp. (CLOV)vs › | $2.43B | 18.57% | 22.55% | 18.71% | 13.63% |
Gross Margin
31.9%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-07-04 | 32.59% |
| 2026-04-04 | 31.24% |
| 2026-01-03 | 31.79% |
| 2025-09-27 | 32.19% |
| 2025-06-28 | 35.76% |
| 2025-03-29 | 32.82% |
| 2024-12-28 | 33.03% |
| 2024-09-28 | 31.37% |
| 2024-06-29 | 31.34% |
| 2024-03-30 | 29.73% |
| 2023-12-30 | 31.00% |
| 2023-09-30 | 30.81% |
| 2023-07-01 | 32.90% |
| 2023-04-01 | 30.97% |
| 2022-12-31 | 28.54% |
| 2022-10-01 | 30.38% |
| 2022-07-02 | 32.74% |
| 2022-04-02 | 32.15% |
| 2022-01-01 | 30.04% |
| 2021-10-02 | 33.98% |
| 2021-07-03 | 33.61% |
| 2021-04-03 | 31.57% |
| 2020-12-31 | 29.89% |
| 2020-09-30 | 31.18% |
| 2020-06-30 | 30.33% |
| 2020-03-31 | 30.27% |
